Squarepoint’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-203
| Closed | -$60.9K | – | 2664 |
|
|
2024
Q1 | $60.9K | Buy |
+203
| New | +$60.9K | ﹤0.01% | 2310 |
|
|
2021
Q3 | – | Sell |
-162
| Closed | -$38K | – | 2425 |
|
|
2021
Q2 | $38K | Buy |
+162
| New | +$38K | ﹤0.01% | 2524 |
|
|
2021
Q1 | – | Sell |
-399
| Closed | -$150K | – | 2737 |
|
|
2020
Q4 | $150K | Buy |
399
+81
| +25% | +$30.5K | ﹤0.01% | 2243 |
|
|
2020
Q3 | $98K | Sell |
318
-178
| -36% | -$54.9K | ﹤0.01% | 2132 |
|
|
2020
Q2 | $187K | Sell |
496
-378
| -43% | -$143K | ﹤0.01% | 1767 |
|
|
2020
Q1 | $199K | Buy |
874
+136
| +18% | +$31K | 0.01% | 1472 |
|
|
2019
Q4 | $390K | Buy |
738
+250
| +51% | +$132K | ﹤0.01% | 1849 |
|
|
2019
Q3 | $210K | Buy |
+488
| New | +$210K | ﹤0.01% | 1959 |
|
|
2019
Q1 | – | Sell |
-841
| Closed | -$797K | – | 2200 |
|
|
2018
Q4 | $797K | Buy |
841
+607
| +259% | +$575K | 0.01% | 1001 |
|
|
2018
Q3 | $337K | Buy |
+234
| New | +$337K | ﹤0.01% | 1476 |
|
|
2017
Q4 | – | Sell |
-375
| Closed | -$524K | – | 2169 |
|
|
2017
Q3 | $524K | Buy |
+375
| New | +$524K | 0.01% | 945 |
|